Published in Biochimie on April 18, 2008
Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev (2013) 2.43
Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg (2010) 1.31
New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention. Clin Perinatol (2010) 1.08
Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen. Interdiscip Perspect Infect Dis (2010) 1.04
Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. J Pediatr (2012) 0.96
Neonatal immune adaptation of the gut and its role during infections. Clin Dev Immunol (2013) 0.95
Breastfeeding protects against acute gastroenteritis due to rotavirus in infants. Eur J Pediatr (2010) 0.95
Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g. Pediatr Infect Dis J (2015) 0.84
Lactoferrin for prevention of neonatal sepsis. Biometals (2014) 0.81
Growth comparison of several Escherichia coli strains exposed to various concentrations of lactoferrin using linear spline regression. Microb Inform Exp (2012) 0.81
The bacterial type III secretion system as a target for developing new antibiotics. Chem Biol Drug Des (2015) 0.81
The burden of different pathogens in acute diarrhoeal episodes among a cohort of Egyptian children less than five years old. Prz Gastroenterol (2015) 0.79
Bovine lactoferrin decreases cholera-toxin-induced intestinal fluid accumulation in mice by ganglioside interaction. PLoS One (2013) 0.79
The effect of UV-C pasteurization on bacteriostatic properties and immunological proteins of donor human milk. PLoS One (2013) 0.79
Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression. J Biotechnol (2013) 0.79
Enteroaggregative coli: A Pathogen Bridging the North and South. Curr Trop Med Rep (2014) 0.78
The Effect of Holder Pasteurization on Nutrients and Biologically-Active Components in Donor Human Milk: A Review. Nutrients (2016) 0.78
Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin. Curr Microbiol (2014) 0.76
Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii. Int J Nanomedicine (2015) 0.75
The Role of Maternal Breast Milk in Preventing Infantile Diarrhea in the Developing World. Curr Trop Med Rep (2014) 0.75
Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial. BMC Pediatr (2015) 0.75
Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection. J Antimicrob Chemother (2016) 0.75
Why whey? Camel whey protein as a new dietary approach to the management of free radicals and for the treatment of different health disorders. Iran J Basic Med Sci (2017) 0.75
Lactoferrin concentration in breast milk of mothers of low-birth-weight newborns. J Perinatol (2017) 0.75
Lactoferrin and prematurity: a promising milk protein? Biochem Cell Biol (2016) 0.75
How many child deaths can we prevent this year? Lancet (2003) 30.39
WHO estimates of the causes of death in children. Lancet (2005) 18.33
Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet (2002) 4.90
Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg (1999) 3.25
Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun (1980) 2.75
Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr (2003) 2.16
Persistent diarrhea signals a critical period of increased diarrhea burdens and nutritional shortfalls: a prospective cohort study among children in northeastern Brazil. J Infect Dis (2000) 2.01
Lactoferrin--a multifunctional protein with antimicrobial properties. Mol Immunol (2003) 1.97
Lactoferrin is a lipid A-binding protein. Infect Immun (1994) 1.73
Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J Pediatr Gastroenterol Nutr (2007) 1.66
Bioactive factors in human milk. Pediatr Clin North Am (2001) 1.45
The physiology of lactoferrin. Biochem Cell Biol (2002) 1.31
Inhibitory effects of human and bovine milk constituents on rotavirus infections. J Dairy Sci (2004) 1.23
Molecular cloning and sequence analysis of bovine lactotransferrin. Eur J Biochem (1991) 1.13
Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol Chem (2001) 1.12
The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe (2007) 1.08
Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother (1993) 1.08
Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. Br J Nutr (2000) 1.05
Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect Immun (2003) 1.03
Iron status of infants fed low-iron formula: no effect of added bovine lactoferrin or nucleotides. Am J Clin Nutr (2002) 1.01
Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli. J Med Microbiol (1995) 0.98
Effect of lactoferrin on enteroaggregative E. coli (EAEC). Biochem Cell Biol (2006) 0.97
Iron, zinc, copper and selenium status of breast-fed infants and infants fed trace element fortified milk-based infant formula. Acta Paediatr (1994) 0.96
Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect Immun (2002) 0.96
Giardicidal activity of lactoferrin and N-terminal peptides. Infect Immun (1995) 0.94
Human lactoferrin impairs virulence of Shigella flexneri. J Infect Dis (2002) 0.93
Binding of lactoferrin and free secretory component to enterotoxigenic Escherichia coli. FEMS Microbiol Lett (2001) 0.92
A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J Pediatr Gastroenterol Nutr (2007) 0.92
Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin Infect Dis (2008) 0.91
Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Escherichia coli to host cells. Biosci Biotechnol Biochem (2000) 0.91
Lactoferrin-binding proteins in Shigella flexneri. Infect Immun (1992) 0.89
Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med Microbiol Immunol (1997) 0.89
Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells. BMC Microbiol (2001) 0.89
Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis? Acta Paediatr (2007) 0.88
Human milk fractions inhibit the adherence of diffusely adherent Escherichia coli (DAEC) and enteroaggregative E. coli (EAEC) to HeLa cells. FEMS Microbiol Lett (2000) 0.87
Supplementation of an adapted formula with bovine lactoferrin. 2. Effects on serum iron, ferritin and zinc levels. Acta Paediatr (1992) 0.86
Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections. APMIS (1991) 0.86
Antiviral activity of lactoferrin towards naked viruses. Biometals (2004) 0.86
Iron availability from an infant formula supplemented with bovine lactoferrin. Acta Paediatr Scand (1991) 0.84
Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection. Biochim Biophys Acta (2001) 0.84
Ultrastructural effects of lactoferrin binding on Giardia lamblia trophozoites. J Eukaryot Microbiol (1997) 0.84
Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity. J Med Virol (2003) 0.83
Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. J Vet Med Sci (2001) 0.83
Protective role of human lactoferrin against invasion of Shigella flexneri M90T. Adv Exp Med Biol (2001) 0.82
Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob Agents Chemother (2003) 0.82
The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J Appl Microbiol (2003) 0.82
Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. J Med Microbiol (2004) 0.82
Human hololactoferrin: endocytosis and use as an iron source by the parasite Entamoeba histolytica. Microbiology (2005) 0.82
Human milk glycoproteins inhibit the adherence of Salmonella typhimurium to HeLa cells. Microbiol Immunol (2006) 0.82
Lactoferrin disruption of bacterial type III secretion systems. Biometals (2004) 0.81
Inv-mediated apoptosis of epithelial cells infected with enteropathogenic Yersinia: a protective effect of lactoferrin. Res Microbiol (2005) 0.78
Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme. Clin Med Res (2006) 0.77
Lactoferrin blocks the initial host cell attachment mechanism of Enteropathogenic E. coli (EPEC). Adv Exp Med Biol (2004) 0.77
Detection of diarrheagenic Escherichia coli by use of melting-curve analysis and real-time multiplex PCR. J Clin Microbiol (2008) 2.11
Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from Periurban areas in Lima, Peru. Clin Infect Dis (2009) 2.09
Quantitative real-time polymerase chain reaction for enteropathogenic Escherichia coli: a tool for investigation of asymptomatic versus symptomatic infections. Clin Infect Dis (2011) 1.42
High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru. Am J Trop Med Hyg (2009) 1.38
Epidemiology and spectrum of disease of Escherichia coli O157. Curr Opin Infect Dis (2003) 1.10
Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect Immun (2003) 1.03
Human milk secretory antibodies against attaching and effacing Escherichia coli antigens. Emerg Infect Dis (2003) 0.97
Effect of lactoferrin on enteroaggregative E. coli (EAEC). Biochem Cell Biol (2006) 0.97
Clinical studies of lactoferrin in children. Biochem Cell Biol (2012) 0.96
Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect Immun (2002) 0.96
Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. J Pediatr (2012) 0.96
Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli. Antimicrob Agents Chemother (2007) 0.95
Human lactoferrin impairs virulence of Shigella flexneri. J Infect Dis (2002) 0.93
Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin Infect Dis (2008) 0.91
Management of children with infection-associated persistent diarrhea. Semin Pediatr Infect Dis (2004) 0.91
Empyema necessitans and acute osteomyelitis associated with community-acquired methicillin-resistant Staphylococcus aureus in an infant. Biomedica (2009) 0.89
Fecal leukocytes in children infected with diarrheagenic Escherichia coli. J Clin Microbiol (2011) 0.88
Multiplex real-time PCR (MRT-PCR) for diarrheagenic. Methods Mol Biol (2013) 0.88
Effect of bovine lactoferrin in Salmonella ser. Typhimurium infection in mice. Biometals (2010) 0.82
Shiga toxin-producing Escherichia coli in Peruvian children with bloody diarrhea. Pediatr Infect Dis J (2012) 0.78
Detection of secretory immunoglobulin A in human colostrum as mucosal immune response against proteins of the type III secretion system of Salmonella, Shigella and enteropathogenic Escherichia coli. Pediatr Infect Dis J (2013) 0.78
Lactoferrin blocks the initial host cell attachment mechanism of Enteropathogenic E. coli (EPEC). Adv Exp Med Biol (2004) 0.77
Development of a multiple gas analyzer using cavity ringdown spectroscopy for use in advanced fire detection. Appl Opt (2009) 0.76
Poliomyelitis-like syndrome in a child with West Nile virus infection. Pediatr Infect Dis J (2004) 0.75